When children living with cancer are treated, their bodies metabolise – or break down – the drugs used in many different ways. The team aim to tailor therapies to individual children based on their drug metabolism, adjusting both the dose and scheduling. We hope that this trail-blazing approach will help reduce the rates of toxicity and recurrence of disease.
Our funding is helping Professor Vaskar and his team to design improved treatment strategies that incorporate highly tailored individual therapies. These will offer decreased toxicity and improved outcomes.